These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Li N, Wang LJ, Jiang B, Li XQ, Guo CL, Guo SJ, Shi DY. Eur J Med Chem; 2018 May 10; 151():145-157. PubMed ID: 29609120 [Abstract] [Full Text] [Related]
3. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else? Juillerat-Jeanneret L. J Med Chem; 2014 Mar 27; 57(6):2197-212. PubMed ID: 24099035 [Abstract] [Full Text] [Related]
4. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. Neumiller JJ. J Am Pharm Assoc (2003); 2009 Mar 27; 49 Suppl 1():S16-29. PubMed ID: 19801361 [Abstract] [Full Text] [Related]